Raymund Rabe Razonable

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis
    Ella J Ariza-Heredia
    William J von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
    Ann Transplant 18:195-204. 2013
  2. doi request reprint Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients
    Raymund R Razonable
    Division of Infectious Diseases, The William J von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
    Infect Dis Clin North Am 27:317-42. 2013
  3. doi request reprint Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients
    Raymund R Razonable
    Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905 0002, USA
    Clin Infect Dis 56:1546-53. 2013
  4. doi request reprint Human herpesviruses 6, 7 and 8 in solid organ transplant recipients
    R R Razonable
    Division of Infectious Diseases, Department of Medicine, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Transplant 13:67-77; quiz 77-8. 2013
  5. doi request reprint Rare, unusual, and less common virus infections after organ transplantation
    Raymund R Razonable
    Division of Infectious Diseases, Department of Medicine, and William J von Leibig Transplant Center, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Curr Opin Organ Transplant 16:580-7. 2011
  6. doi request reprint Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review
    R R Razonable
    Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Transpl Infect Dis 10:413-8. 2008
  7. pmc Antiviral drugs for viruses other than human immunodeficiency virus
    Raymund R Razonable
    Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:1009-26. 2011
  8. ncbi request reprint A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Infect Dis 192:1349-54. 2005
  9. doi request reprint Immune-based therapies for cytomegalovirus infection
    Raymund R Razonable
    Division of Infectious Diseases, Mayo Clinic, Marian Hall 5, 200 First Street SW, Rochester, MN 55905, USA
    Immunotherapy 2:117-30. 2010
  10. pmc Cytomegalovirus infection after liver transplantation: current concepts and challenges
    Raymund Rabe Razonable
    Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Gastroenterol 14:4849-60. 2008

Collaborators

Detail Information

Publications54

  1. doi request reprint Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis
    Ella J Ariza-Heredia
    William J von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
    Ann Transplant 18:195-204. 2013
    ..Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies...
  2. doi request reprint Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients
    Raymund R Razonable
    Division of Infectious Diseases, The William J von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
    Infect Dis Clin North Am 27:317-42. 2013
    ..This article provides a comprehensive review of the current epidemiology, diagnosis, prevention and treatment of CMV infection in solid organ transplant recipients...
  3. doi request reprint Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients
    Raymund R Razonable
    Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905 0002, USA
    Clin Infect Dis 56:1546-53. 2013
    ..Using the World Health Organization (WHO) international standard for reporting, we correlated viral load with CMV disease resolution...
  4. doi request reprint Human herpesviruses 6, 7 and 8 in solid organ transplant recipients
    R R Razonable
    Division of Infectious Diseases, Department of Medicine, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Transplant 13:67-77; quiz 77-8. 2013
    ..Sirolimus has been shown to be a beneficial component for the treatment of Kaposi's sarcoma and the role of antivirals for HHV-8 infection is being investigated...
  5. doi request reprint Rare, unusual, and less common virus infections after organ transplantation
    Raymund R Razonable
    Division of Infectious Diseases, Department of Medicine, and William J von Leibig Transplant Center, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Curr Opin Organ Transplant 16:580-7. 2011
    ..The present article reviews the epidemiology, clinical presentation, prevention, and management of rare, unusual, and less common viruses that infect transplant recipients...
  6. doi request reprint Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review
    R R Razonable
    Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Transpl Infect Dis 10:413-8. 2008
    ..Intraocular vancomycin, intravenous ceftriaxone, and prolonged course of oral trimethoprim-sulfamethoxazole therapy led to clinical improvement and recovery of visual acuity...
  7. pmc Antiviral drugs for viruses other than human immunodeficiency virus
    Raymund R Razonable
    Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:1009-26. 2011
    ..This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects...
  8. ncbi request reprint A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Infect Dis 192:1349-54. 2005
    ..Hence, BKV and JCV DNAemia are not uncommon during the first year after kidney, heart, liver, and pancreas transplantation, and they could be associated with certain clinical syndromes in transplant patients...
  9. doi request reprint Immune-based therapies for cytomegalovirus infection
    Raymund R Razonable
    Division of Infectious Diseases, Mayo Clinic, Marian Hall 5, 200 First Street SW, Rochester, MN 55905, USA
    Immunotherapy 2:117-30. 2010
    ..The benefits of immunoglobulins remain debated in an era when antiviral therapy is widely available. CMV vaccination and adoptive immunotherapy, on the other hand, remain experimental, but have had encouraging preliminary results...
  10. pmc Cytomegalovirus infection after liver transplantation: current concepts and challenges
    Raymund Rabe Razonable
    Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Gastroenterol 14:4849-60. 2008
    ..In this article, the author reviews the current state and the future perspectives of prevention and treatment of CMV disease after liver transplantation...
  11. ncbi request reprint Viral infections in transplant recipients
    R R Razonable
    Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Minerva Med 100:479-501. 2009
    ..Prevention of viral infections is therefore of utmost importance, and this may be accomplished through vaccination, antiviral strategies, and aggressive infection control measures...
  12. doi request reprint Strategies for managing cytomegalovirus in transplant recipients
    Raymund R Razonable
    William J von Liebig Transplant Center, College of Medicine, Mayo Clinic, Division of Infectious Diseases, Department of Internal Medicine, Rochester, MN 55905, USA
    Expert Opin Pharmacother 11:1983-97. 2010
    ..Cytomegalovirus (CMV) is the most important pathogen that affects transplant recipients, by directly causing clinical disease and by indirectly reducing patient and allograft survival...
  13. doi request reprint Management of viral infections in solid organ transplant recipients
    Raymund R Razonable
    Division of Infectious Diseases, Department of Medicine, and the William J von Leibig Transplant Center, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Expert Rev Anti Infect Ther 9:685-700. 2011
    ....
  14. doi request reprint Human herpes virus 8 in solid organ transplantation
    Ella J Ariza-Heredia
    Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Transplantation 92:837-44. 2011
    ..The mammalian target of rapamycin inhibitor sirolimus may have the potential for management because of its antiproliferative properties. The role of antiviral drugs for HHV-8 prevention and treatment is yet to be defined...
  15. ncbi request reprint Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease
    Raymund R Razonable
    Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Infect Dis 192:1331-9. 2005
    ..Compared with historic data, data from the present study suggest that antiviral prophylaxis may lower the incidence, prevalence, or level of DNAemia for infection with HHV-6, HHV-8, VZV, and EBV but not for infection with HHV-7...
  16. pmc Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism
    Raymund R Razonable
    Division of Infectious Diseases, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Antimicrob Agents Chemother 49:3546-9. 2005
    ..Hence, a TLR-dependent mechanism could serve as the molecular basis for the proinflammatory properties of nystatin...
  17. ncbi request reprint Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Toxicol Appl Pharmacol 210:181-9. 2006
    ..Whether bleomycin engages with other cellular receptors that results in activation of alternate signaling pathways and whether the TLR2-agonist activity of bleomycin contribute to its anti-neoplastic property deserve further study...
  18. ncbi request reprint Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir
    R R Razonable
    Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Infect Dis 184:1461-4. 2001
    ....
  19. pmc Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Antimicrob Agents Chemother 49:1617-21. 2005
    ..Hence, TLR2-TLR1 coactivation serves as the underlying mechanism for the proinflammatory toxicities associated with AmB...
  20. ncbi request reprint Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:1153-6. 2003
    ..We highlight the predilection of F necrophorum to cause a potentially fatal septic illness irrespective of its primary focus and emphasize the importance of this bacterium as a cause of considerable morbidity...
  21. ncbi request reprint Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy
    R R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 76:1171-5. 2001
    ....
  22. ncbi request reprint Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts
    Raymund R Razonable
    Mayo Clinic College of Medicine, Mayo Foundation Scholar, Division of Infectious Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Expert Rev Anti Infect Ther 2:27-41. 2004
    ....
  23. ncbi request reprint Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients
    Raymund R Razonable
    Mayo Clinic College of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am J Health Syst Pharm 62:S7-13. 2005
    ....
  24. ncbi request reprint Management of CMV infection and disease in transplant patients. 27-29 February 2004
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine at the Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Herpes 11:77-86. 2004
    ..This article presents supporting evidence for these recommendations and statements...
  25. ncbi request reprint Delayed-onset primary cytomegalovirus disease after liver transplantation
    Supha K Arthurs
    Division of Infectious Diseases, William J von Liebig Transplant Center, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Liver Transpl 13:1703-9. 2007
    ..Female patients and younger patients are at increased risk of delayed-onset primary CMV disease...
  26. ncbi request reprint Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Infect Dis 187:1801-8. 2003
    ..This study identifies a relative cutoff virus load that predicts subsequent development of CMV disease and highlights the inability of oral ganciclovir to suppress CMV replication in a subset of patients...
  27. ncbi request reprint Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Clin Transplant 17:114-20. 2003
    ..Thus, HHV-7 (and HHV-6) should be considered as a pathogen (or copathogen) in the viral syndromes following organ transplantation...
  28. ncbi request reprint Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients
    Supha Kijpittayarit-Arthurs
    Division of Infectious Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Heart Lung Transplant 26:1019-24. 2007
    ..This study was conducted to investigate the incidence, clinical features, risk factors and outcome of delayed-onset primary CMV disease in cardiac recipients who received anti-CMV prophylaxis...
  29. doi request reprint Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
    Albert J Eid
    Division of Infectious Diseases, The William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Transplant 22:162-70. 2008
    ..We assessed the incidence, clinical features, and outcome of drug-resistant CMV among solid organ transplant patients who received valganciclovir prophylaxis...
  30. doi request reprint New developments in the management of cytomegalovirus infection after solid organ transplantation
    Albert J Eid
    Division of Infectious Diseases, University of Kansas Medical Center, Kansas City, Kansas, USA
    Drugs 70:965-81. 2010
    ..This article reviews the recent data and other developments in the management of CMV infection after SOT...
  31. doi request reprint A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection
    Albert J Eid
    Divisions of Infectious Diseases, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA
    Transpl Int 23:506-13. 2010
    ..On the other hand, the clinical utility of CMV-specific T cell assays will need to be assessed in a larger cohort of CMV D+/R- kidney recipients who remain at high-risk of delayed-onset CMV disease...
  32. pmc The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus
    Robert A Brown
    Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Infect Dis 49:e96-9. 2009
    ..This immunologic impairment could serve as a biologic mechanism underlying the association between the TLR2 R753Q polymorphism and cytomegalovirus disease in humans...
  33. doi request reprint Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy
    Robert A Wermers
    Department of Internal Medicine, Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 First Street S W, Rochester, MN 55905, USA
    Clin Infect Dis 52:604-11. 2011
    ..Elevated plasma and bone fluoride levels were identified. Discontinuation of voriconazole therapy led to improvement in pain and reduced fluoride and alkaline phosphatase levels...
  34. ncbi request reprint A young man with pyomyositis and bullous disease
    Albert J Eid
    Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Infect Dis 45:741, 799-800. 2007
  35. ncbi request reprint Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation
    Supha Kijpittayarit
    Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Infect Dis 44:1315-20. 2007
    ....
  36. ncbi request reprint The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine and Transplant Center, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Transplantation 73:968-73. 2002
    ..However, a consensus as to what is the optimal blood compartment for the detection and quantitation of CMV DNA in peripheral blood is nonexistent...
  37. pmc Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Clin Microbiol 40:746-52. 2002
  38. pmc R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins
    Robert A Brown
    Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
    Transplantation 89:811-5. 2010
    ..Individuals with the R753Q single-nucleotide polymorphism (SNP) in the TLR2 gene have increased the risk of allograft failure after liver transplantation for chronic hepatitis C...
  39. doi request reprint Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
    Supha K Arthurs
    Divisions of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Infect Dis 46:840-6. 2008
    ..We evaluated the incidence, clinical features, risk factors, and outcomes of CMV disease among high-risk kidney transplant recipients...
  40. ncbi request reprint Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Herpes 10:60-5. 2003
    ..This review highlights the current challenges in managing CMV and Epstein-Barr virus infections in transplant patients...
  41. pmc Human herpesvirus 6 infections after liver transplantation
    Rima Camille Abdel Massih
    Division of Infectious Diseases, Department of Medicine, and the William J von Liebig Transplant Center, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    World J Gastroenterol 15:2561-9. 2009
    ..This article reviews the current advances in the pathogenesis, clinical diagnosis, and therapeutic modalities against HHV6 in the setting of liver transplantation...
  42. ncbi request reprint Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus
    Albert J Eid
    Division of Infectious Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Transplantation 84:511-6. 2007
    ..We assessed the association between the single nucleotide polymorphism in genes that encode for these receptors and the outcome of liver transplantation for chronic HCV...
  43. ncbi request reprint Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy
    Helen B Viscount
    Division of Clinical Microbiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Transplantation 84:340-5. 2007
    ..A noninvasive assay that can guide the evaluation of PVAN would be of clinical value. We compared the utility of BK virus (BKV) polymerase chain reaction (PCR) and urine cytology in screening for concurrent PVAN...
  44. ncbi request reprint Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C
    Kelly W Burak
    Transplant Center, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Liver Transpl 8:362-9. 2002
    ..Whether CMV mediates this by inducing increased immunosuppression or directly enhancing HCV replication requires further study...
  45. ncbi request reprint Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients
    Ariel E Feldstein
    Division of Pediatric Gastroenterology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Pediatr Transplant 7:125-9. 2003
    ..In this study, HHV-6 infection occurred in 9% of pediatric liver transplant patients while HHV-7 was not detected. A potential association between primary HHV-6 infection and allograft rejection warrants further investigation...
  46. ncbi request reprint Parvovirus B19 infection after transplantation: a review of 98 cases
    Albert J Eid
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Infect Dis 43:40-8. 2006
    ..Infections with parvovirus B19 (PVB19) can cause significant morbidity in transplant recipients...
  47. pmc Capnocytophaga canimorsus a novel pathogen for joint arthroplasty
    A Noelle Larson
    Department of Orthopaedics, Mayo Clinic, Rochester, MN, USA
    Clin Orthop Relat Res 467:1634-8. 2009
    ..Because of its fastidious and slow-growing characteristics, C. canimorsus may be an unrecognized cause of culture-negative joint arthroplasty infections, especially in cases when dog and cat exposure is evident in the clinical history...
  48. doi request reprint Chromosomally integrated human herpesvirus-6 in kidney transplant recipients
    Sang Oh Lee
    Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 26:2391-3. 2011
    ..This entity, termed chromosomally integrated HHV-6 (CIHHV-6), is often mistaken as active infection and treated unnecessarily. The prevalence of CIHHV-6 in kidney transplant recipients is not known...
  49. doi request reprint Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy?
    Odette C El Helou
    Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Infect Dis 47:903-9. 2008
    ..The optimal medical or surgical therapy and outcome of enterococcal prosthetic joint infection are unknown...
  50. ncbi request reprint The pathogenesis of hepatitis C virus is influenced by cytomegalovirus
    Raymund R Razonable
    Division of Infectious Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Clin Infect Dis 35:974-81. 2002
    ..05) and had a trend toward a higher hepatitis activity index (P=.10) and HCV load (P=.10) at 16 weeks after liver transplantation. The pathogenesis of HCV is influenced by its interaction with CMV but not with HHV-6...
  51. ncbi request reprint Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature
    Albert J Eid
    Division of Infectious Diseases, Department of Medicine, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Infect Dis 45:687-94. 2007
    ..Prosthetic joint infection (PJI) due to rapidly growing mycobacteria (RGM) is only occasionally encountered in clinical practice. Therefore, the optimal clinical management for this condition is unknown...
  52. ncbi request reprint Graft-vs.-host disease in lung and other solid organ transplant recipients
    Maha A Assi
    Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Transplant 21:1-6. 2007
    ..The mortality rate was high (30%). The cause of death was mainly due to infection, suggesting that antimicrobial prophylaxis may improve the outcome of this potentially fatal complication...
  53. doi request reprint The impact of invasive fungal diseases on survival after lung transplantation
    Supha K Arthurs
    Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Clin Transplant 24:341-8. 2010
    ..Recipients of lung transplants are at high risk of infectious complications. We investigated the epidemiology of infections after lung transplantation and determined their impact on survival...